Are you Dr. Ahsan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 7 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 N Wolfe St
Cmsc 2-124
Baltimore, MD 21287Phone+1 410-955-2727- Is this information wrong?
Summary
- Dr. Sama Ahsan, MD is a pediatric hematologist/oncologist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Pennsylvania.
Education & Training
State University of New York Downstate Medical Center College of MedicineClass of 2008
Certifications & Licensure
PA State Medical License 2016 - 2024
MD State Medical License 2011 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States.Xiaoqin Yang, Rose Chang, Theresa Dettling, Raj Desai, Chi Gao, Azeem Banatwala, Sydney Ng, Mei Sheng Duh, Sama Ahsan> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
- 4 citationsPaediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medic...Andrew Dj Pearson, Carl Allen, Jason Fangusaro, Caroline Hutter, Olaf Witt, Susan Weiner, Gregory Reaman, Mark Russo, Pratiti Bandopadhayay, Sama Ahsan, Amy Barone, El...> ;European Journal of Cancer. 2022 Dec 1
- 163 citationsPembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.Jason J Luke, Piotr Rutkowski, Paola Queirolo, Michele Del Vecchio, Jacek Mackiewicz, Vanna Chiarion-Sileni, Luis de la Cruz Merino, Muhammad A Khattak, Dirk Schadendo...> ;Lancet. 2022 Apr 30
- Join now to see all
Press Mentions
- Immunotherapy Drug Benefits Patients with High-Risk Local MelanomasSeptember 18th, 2021
